ArticleBJPsych open2024

Investigating patient eligibility for anti-amyloid monoclonal antibody treatment of Alzheimer's disease: real-world data from an Austrian psychiatric memory clinic population.

Michaela Defrancesco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.